EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0

Gad Abikhzer iD, Giorgio Treglia iD, Matthieu Pelletier-Galarneau iD, John Buscombe iD, Arturo Chiti iD, Elizabeth H Dibble iD, Andor W J M Glaudemans iD, Christopher J Palestro iD, Mike Sathekge iD, Alberto Signore iD, Francois Jamar iD, Ora Israel iD und 1 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2025-01 · 52 (2) · 510-538

DOI: 10.1007/s00259-024-06915-3 ↗

Kurz gefasst

Leitlinie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 10.10.2024. Verfasst von Gad Abikhzer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Faculty of Medicine and Health Sciences, Jewish General Hospital, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Inflammation, Positron-Emission Tomography, Infections. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 194 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hybrid [ 18 F]FDG PET imaging is currently the method of choice for a wide variety of infectious and inflammatory disorders and was recently adopted in several clinical guidelines. A large amount of evidence-based articles, guidelines and appropriate use criteria have been published since the first version of this guideline in 2013.

Purpose

To provide updated evidence-based information to assist physicians in recommending, performing and interpreting hybrid [ 18 F]FDG PET examinations for infectious and inflammatory disorders in the adult population.

Methods

A systematic literature search of evidence-based articles using whole-body [ 18 F]FDG hybrid imaging on the indications covered within this guideline was performed. All systematic reviews and meta-analyses published within the last 10 years until January 2023 were identified in PubMed/Medline or Cochrane. For each indication covered in this manuscript, diagnostic performance was provided based on meta-analyses or systematic reviews. If not available, results from prospective or retrospective studies were considered based on predefined selection criteria. Results and conclusions Hybrid [ 18 F]FDG PET is extremely useful in the work-up and management of adults with infectious and inflammatory diseases, as supported by extensive and rapidly growing evidence-based literature and adoption in clinical guidelines. Practical recommendations are provided describing evidence-based indications as well as interpretation criteria and pitfalls. Monitoring treatment response is the most challenging but insufficiently studied potential application in infection and inflammation imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18InflammationPositron-Emission TomographyInfectionsNuclear MedicineHumansAdultRadiopharmaceuticals

Stichwörter der Autor:innen

GuidelineInfectionInflammationPET/CTProcedure standard[18F]FDG

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Medical Imaging, Faculty of Medicine and Health Sciences, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
  • Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
  • Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
  • Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900, Lugano, Switzerland.
  • Department of Medical Imaging, Montreal Heart Institute, Montreal, Quebec, Canada.
  • Department of Nuclear Medicine, Cambridge University Hospitals, Cambridge, United Kingdom.

ORCID-Profile: Gad Abikhzer, Giorgio Treglia, Matthieu Pelletier-Galarneau, John Buscombe, Arturo Chiti, Elizabeth H Dibble, Andor W J M Glaudemans, Christopher J Palestro, Mike Sathekge, Alberto Signore, Francois Jamar, Ora Israel, Olivier Gheysens

Zitieren

APA

Abikhzer, G., Treglia, G., Pelletier-Galarneau, M., Buscombe, J., Chiti, A., Dibble, E. H., Glaudemans, A. W. J. M., Palestro, C. J., Sathekge, M., Signore, A., Jamar, F., Israel, O., & Gheysens, O. (2025). EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0. European Journal of Nuclear Medicine and Molecular Imaging, 52(2), 510-538. https://doi.org/10.1007/s00259-024-06915-3

Vancouver

Abikhzer G, Treglia G, Pelletier-Galarneau M, Buscombe J, Chiti A, Dibble EH, et al. EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(2):510-538. doi:10.1007/s00259-024-06915-3

BibTeX
@article{Abikhzer2025,
  author = {Abikhzer, Gad and Treglia, Giorgio and Pelletier-Galarneau, Matthieu and Buscombe, John and Chiti, Arturo and Dibble, Elizabeth H and Glaudemans, Andor W J M and Palestro, Christopher J and Sathekge, Mike and Signore, Alberto and Jamar, Francois and Israel, Ora and Gheysens, Olivier},
  title = {EANM/SNMMI guideline/procedure standard for [18F]FDG hybrid PET use in infection and inflammation in adults v2.0},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {52},
  number = {2},
  pages = {510--538},
  doi = {10.1007/s00259-024-06915-3}
}
Kostenlos starten →